Longboard Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies to address the needs of patients with neurological disorders

The company specializes in the research and development of cannabinoid-based medications, leveraging its proprietary technology to create novel treatments aimed at improving the quality of life for individuals suffering from conditions such as epilepsy and other related ailments. Longboard is dedicated to advancing its clinical programs and fostering collaborations within the medical and scientific communities to bring new hope to patients in need.